May 4 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- BOARD UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT THE OFFER BY AUSTRALIAN CLINICAL LABS
- BOARD IS NOT OPPOSED TO ENGAGING IN DISCUSSIONS WITH ACL, OR ANOTHER PARTY, IN RELATION TO A CONTROL TRANSACTION OR MERGER PROPOSAL
- UNSOLICITED CONDITIONAL OFFER "OPPORTUNISTICALLY TIMED" AND WOULD RESULT IN AN "UNFAIR TRANSFER OF VALUE" FROM CO'S SHAREHOLDERS TO ACL
News: ACL Healius Ltd Board Recommends Shareholders Reject Australian Clinical Labs' Offer
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
-0.010(0.35%) |
Mkt cap ! $551.8M | |||
| Open | High | Low | Value | Volume |
| $2.83 | $2.83 | $2.78 | $1.879M | 670.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20909 | $2.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.83 | 8688 | 4 |
View Market Depth
| Last trade - 16.14pm 29/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |